Non phosphocalcic actions of vitamin D;Effets non osseux de la vitamine D

Medecine/Sciences

Volumn 26, Issue 4, 2010, Pages 417-421

  Courbebaisse, Marie ^a,b   Souberbielle, Jean Claude ^c,d   Prié, Dominique ^c,d   Thervet, Éric ^c  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951853708     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2010264417     Document Type: Review

References (32)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007 357: 266-281
2. Souberbielle JC, Prie D, Courbebaisse M, et al. Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol (Paris) 2008 69: 501-510
3. Tretli S, Hernes E, Berg JP, et al. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009 100: 450-454
4. Tuohimaa P, Tenkanen L, Ahonen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004 108: 104-108
5. Fleet JC. Molecular actions of vitamin D contributing to cancer prevention. Mol Aspects Med 2008 29: 388-396
6. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684-696 (Pubitemid 43247139)
7. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007 85: 1586-1591
8. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. Clin Endocrinol Metab 2007; 92: 2017-2029 (Pubitemid 46997093)
9. Sun X, Zemel MB. Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity 2007 15: 340-348
10. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the shortterm effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middleaged, centrally obese men. Diabet Med 2009 26: 19-27.
11. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008 117: 503-511
12. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008 93: 3927-3935
13. London GM, Guerin AP, Verbeke FH, et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007 18: 613-620
14. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005 94: 483-492
15. Cardus A, Parisi E, Gallego C, et al. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney lnt 2006 69: 1377-1384
16. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008 29: 726-776
17. Nakagawa K, Sasaki Y, Kato S, et al. 22-Oxa-lalpha, 25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 2005 26: 1044-1054
18. Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009 94: 4023-4030
19. Witham MD, Nadir MA, Strutfiers AD. Effect of vitamin D on blood pressure' a systematic review and meta-analysis. Hypertens 2009 27: 1948-1954
20. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2010 (sous presse).
21. Tanaci N, Karakose H, Guvener N, et al. Influence of 1,25- dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: a retrospective cohort study. Transplant Proc 2003 35: 2885-2887
22. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006 311: 1770-1773
23. Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect 2007 135: 1095-1096
24. Li YC. Renoprotective effects of vitamin D analogs. Kidney lnt 2010 (sous presse).
25. Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney lnt 2009 75: 88-95.
26. Sun J, Kong J, Duan Y, et al. Increased NF-κ B activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006 291: E315-22.
27. Alborzi P, Patel NA, Peterson C, et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 2008 52: 249-255
28. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopema): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab 2003 88: 5766-5772
29. Bischoff-Ferrari HA, Willett WC, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005 293: 2257-2264
30. Autier P, Gandini S. Vitamin D supplementation and total mortality: a metaanalysis of randomized controlled trials. Arch Intern Med 2007 167: 1730-1737
31. Tissandié E, Guéguen Y, Lobaccaro JM, et al. Vitamine D: métabolisme, régulation et maladies associées. Med Sci (Paris) 2006 22: 1095-1100
32. Prié D, Ureña Torres P, Friedlander G. Le facteur de croissance des fibroblastes 23 et son récepteur Klotho: un nouvel axe de régulation du bilan du phosphate. Med Sci (Paris) 2009 25: 489-495